Close Menu

St. Jude

Researchers at St. Jude and elsewhere identified a promoter SNP associated with peripheral neuropathy in vincristine-treated children with acute lymphoblastic leukemia.

By testing hundreds of children with brain tumors who were treated with cisplatin, researchers identified risk variants related to cisplatin ototoxicity.

NEWYORK (GenomeWeb) – Personalized medicine proponents have long argued that pharmacogenomics can increase drug efficacy and reduce dangerous adverse outcomes, especially if PGx information is collected and stored preemptively so that it can be available at the point of prescribing and useful in

NEW YORK (GenomeWeb) – In a genomic study of the childhood cancer acute lymphoblastic leukemia, a St. Jude Children's Research Hospital-led team participating in the Pediatric Cancer Genome Project has tracked down recurrent alterations that may be susceptible to tyrosine kinase inhibitors.

SAN DIEGO — St. Jude Children's Research Hospital is developing a clinical sequencing pipeline in which it plans to enroll every incoming pediatric oncology patient. James Downing, scientific director of St.

Nashville, Tenn.-based Insight Genetics said this week that it has launched Insight Molecular Labs, a CLIA-certified laboratory.

NEW YORK (GenomeWeb News) – A study in Nature Genetics suggests inherited variants in a gene called GATA3 can dial up children's risk of developing an especially aggressive form of pediatric acu

Insight Genetics this week announced an exclusive, worldwide licensing deal with St. Jude Children's Research Hospital for a genetic test to improve donor matching in bone marrow transplants.

NEW YORK (GenomeWeb News) – Insight Genetics today announced an exclusive, worldwide licensing deal with St. Jude Children's Research Hospital for a genetic test to improve donor matching in bone marrow transplants.

Pages

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.